AnnAidA Technologies
Seed Round in 2025
Founded in 2019, AnnAidA Technologies specializes in developing innovative devices for biochemical research. Its flagship product, EmbryoSpin, enables chemical analysis at the scale of a single human embryo using microscopic Nuclear Magnetic Resonance technology.
DePoly is a chemical recycling company that converts post-consumer PET plastic and polyester textiles into virgin-quality raw materials at room temperature. This process enables a circular plastic economy by eliminating the need for pre-washing, sorting, or separation of other plastics.
AICA SA
Seed Round in 2025
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
DPhi Space
Pre Seed Round in 2025
DPhi Space is developing ridesharing platforms for space access democratization. Their goal is to provide affordable infrastructure, enabling faster deployment of software or hardware in orbit.
Eleven Dynamics
Seed Round in 2025
Eleven Dynamics develops software technology that automates industrial quality control. Its solutions enable clients to design and simulate custom quality processes, automatically program optimal measurement paths without requiring robotic expertise, connect hardware in real-time, and execute measurements.
Grand Resort Bad Ragaz
Debt Financing in 2024
Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.
Founded in 2013, Embotech develops decision-making software solutions for autonomous systems. Its flagship product, FORCES Pro, enables complex control system design across industries such as automotive, energy, and robotics. Applications include wind turbine control, drone motion planning, advanced driver assistance systems (ADAS), spacecraft landing, and reusable rocket returns.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Somagenetix
Series A in 2024
Somagenetix is a biotechnology company specializing in gene therapy aimed at treating phagocyte-related illnesses. The firm focuses on developing innovative treatments for conditions such as immunodeficiency, neurodegeneration, and cancer with brain metastases. By utilizing genetically modified phagocytes, Somagenetix seeks to improve patient outcomes through targeted therapies. Additionally, the company is engaged in the discovery and development of stem cells derived from bone marrow and therapeutic genes from lentiviral vectors. This approach enables the correction of underlying genetic defects and the transplantation of gene-corrected cells back into patients, with the goal of curing various monogenetic diseases. Through its pioneering efforts, Somagenetix aspires to be a leader in the gene therapy sector.
Lymphatica Medtech
Series B in 2024
Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.
askEarth
Seed Round in 2024
AskEarth is a geospatial intelligence platform offering real-time insights from its proprietary search engine. It specializes in monitoring environmental changes such as deforestation, coastline progressions, and glacier melting, providing clients with accurate data to predict Earth's future.
Isochronic
Seed Round in 2024
Isochronic is a manufacturer of advanced industrial robotic products designed for pick-and-place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thus enhancing efficiency in high-volume production lines. By enabling industries to automate their operations, Isochronic significantly increases the number of products processed at any given time while optimizing the use of factory floor space. Its innovative approach aims to revolutionize the traditional pick-and-place methods, providing businesses with the tools necessary for streamlined operations and enhanced productivity.
Calingo
Seed Round in 2024
Calingo is a digital insurance platform that specializes in providing personalized and optimized risk protection directly at the point of sale. The company focuses on offering customized insurance products designed to meet individual customer needs, ensuring transparency and fairness in pricing. By leveraging technology, Calingo aims to deliver tailored insurance solutions that are both suitable and transparent for customers.
Complementa
Acquisition in 2024
Complementa, established in 1984 and based in Saint Gallen, Switzerland, offers a range of services to support investors. These include consolidated performance reporting, accounting, investment consulting, and investment control. The company assists clients in planning, designing, and monitoring their investment and financing processes.
Drone Harmony
Venture Round in 2024
Founded in 2016, Drone Harmony specializes in developing software for cost-effective deployment of drone technology in industries where traditional methods fall short. Its flagship product is a 3D flight planning platform that transforms users into professional inspection operators by automating complex industrial tasks.
Synthara
Venture Round in 2024
Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.
Microcaps
Series A in 2024
Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.
DataHow AG is a spin-off from ETH Zurich that specializes in data analytics and process modeling for the biopharmaceutical and chemical industries. The company offers digital solutions and consulting services aimed at optimizing process monitoring and scale-up. By focusing on reducing effort, risks, and costs associated with process development, DataHow enhances clients' understanding of complex manufacturing processes. Their services include process screening, monitoring, optimization, and control, providing technological support that enables businesses in these sectors to improve efficiencies in manufacturing and development.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Testmate Health
Seed Round in 2024
Testmate Health is a medtech startup and award-winning spin-off of the University of Geneva in Switzerland. It has developed a smartphone-compatible platform test kit capable of diagnosing diseases based on identifiable DNA or RNA sequences without the need for a laboratory, delivering results in minutes at home. The initial product is a rapid urine self-test for the four most common sexually transmitted infections, designed to be used outside clinical settings and to provide a smartphone-scanable result that supports immediate access to treatment if needed. The platform uses DNA isothermal technology to detect infectious diseases with identifiable DNA, enabling home testing without laboratory submission. Further test kits for additional diseases are in development to empower users to monitor their health from home.
Bcomp Ltd., founded in 2003 and headquartered in Fribourg, Switzerland, specializes in manufacturing natural fiber composites. The company's primary products include ampliTex (natural flax fiber), bCores (lightweight wood core), and powerRibs (natural fiber composite reinforcement). Bcomp serves industries such as sports, automotive, acoustics, aerospace, electronics, design, and leisure by providing eco-friendly alternatives to traditional materials.
progile
Seed Round in 2024
Autonomous Testing with Zero Flakiness.
The TrueTest Technology and our AI-based virtual user makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach.
We simplified automated testing massively and reduced time radically.
With it, the automation and maintenance effort is reduced to a minimum: zero flakiness and the enlightening feeling of being in control of your automation and test scenarios.
It's not about buzzwords and being one of the cool kids. Our mission was to solve the daily problems of test automation. And that's what we did.
OUR TECHNOLOGY
Stop losing your time on tasks automation should have eliminated
The power of TestResults.io lies in its core, the TrueTest technology. It includes Visual Matching, Visual Sense, and Codified Expertise.
Visual Matching
Identifies elements in a technology-agnostic way through image convolution, text detection, and our unique ReverseOCR
Visual Sense
Identifies interaction position without hints to solve flakiness with spatial algorithms and automatic candidate selection.
It doesn’t matter if the label is outside or inside, above, left from the field or anywhere else. It doesn’t matter if the position changes in a responsive layout. Visual Sense, always knows what label is related to which field.
Codified Expertise
Knows how to interact with elements through autonomous interactions and automatic verification.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.
Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.
Cultivated Biosciences
Seed Round in 2024
Cultivated Biosciences is a food production company that develops specialized fat ingredients from oleaginous yeast. These ingredients enhance the creaminess and mouthfeel of plant-based dairy products, such as cheese and yogurt alternatives.
Food Brewer
Seed Round in 2024
Food Brewer AG is a Switzerland-based company specializing in the development and marketing of innovative food and food ingredients through the use of plant cell cultures. By employing technologies similar to beer brewing for large-scale cultivation in fermenters, Food Brewer provides sustainable alternatives to traditional agriculture. The company focuses on securing essential resources for the food industry while addressing geographic, climatic, and ethical uncertainties associated with conventional farming practices. Its product offerings include alternatives to cocoa, coffee, nuts, and grains, catering to the evolving needs of clients seeking sustainable food solutions.
Artiria Medical
Series A in 2024
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.
Qumea is a technology company that provides discreet, contactless patient monitoring for healthcare institutions. Its solution combines artificial intelligence with 3D radar to monitor patient movement without physical contact, delivering real-time alerts, data analytics, and integration with hospital systems to enhance patient safety, reduce fall risk, and improve workflow efficiency.
BTRY
Pre Seed Round in 2024
BTRY, spun off from EMPA and ETH, specializes in developing the first energy-dense solid-state battery, leveraging advanced semiconductor manufacturing techniques. The company aims to provide a sustainable energy storage solution, offering customizable battery properties to meet diverse customer needs, thereby reducing energy consumption and waste from solvent evaporation and recycling.
ENANTIOS
Venture Round in 2024
Scientific Instrumentation and Services
Gerald Group
Debt Financing in 2024
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
Aesyra is a Swiss medical device company based in Lausanne that designs and commercializes intra-oral sensors and compact oral appliances to monitor and manage sleep-related conditions such as bruxism and obstructive sleep apnea. The company develops devices that embed sensors to collect and display metrics, enabling dental professionals to reduce occlusal damages to dental prostheses and helping individuals pursue better sleep. Its offerings include an oral appliance with a customizable liner for optimal fit and sensor-enabled monitoring and management tools for clinicians and patients.
Onena Medicines
Venture Round in 2023
Onena Medicines is a biotechnology company developing innovative biological medicines. It focuses on addressing large unmet clinical needs for breast cancer and other serious orphan illnesses.
Helio
Debt Financing in 2023
Helio optimizes cloud computing resources for minimal emissions and competitive pricing. Its platform enables professionals in fields like architecture, animation, and design to efficiently manage 3D rendering workloads.
Nagi Bioscience
Series A in 2023
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.
Tune Insight
Seed Round in 2023
Tune Insight is a developer of data security software that facilitates secure collaborations on sensitive data among multiple organizations. The company employs advanced collective analytics, privacy measures, and encryption technologies to enable federated learning. This approach allows participants to derive insights collectively while maintaining full control over their own data. By focusing on secure data sharing, Tune Insight empowers organizations to make informed decisions collaboratively, ensuring both data integrity and privacy throughout the process.
Hylomorph
Series B in 2023
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Nezasa
Venture Round in 2023
Nezasa offers a unified platform for planning and booking personalized multi-product or multi-stop itineraries. It combines the services of a traditional travel agency with the cost benefits of an online portal, enabling seamless end-to-end experiences for global travel brands.
DePoly is a chemical recycling company that converts post-consumer PET plastic and polyester textiles into virgin-quality raw materials at room temperature. This process enables a circular plastic economy by eliminating the need for pre-washing, sorting, or separation of other plastics.
Distran develops advanced acoustic sensing technology to improve safety and environmental performance in industrial settings. Originating from ETH Zurich's Autonomous System Lab, the company creates phased-array ultrasound sensors that spatially filter background noise to locate defects such as leaks or discharges from a safe distance, addressing limits of traditional sensors. The technology enables remote, early defect detection and non-contact monitoring, supporting safer work practices and reduced environmental impact. Distran serves industries including oil and gas, power generation, chemistry, and composite engineering, helping operators monitor machinery, identify issues promptly, and optimize maintenance. By combining directional sensing with robust performance in noisy environments, the company aims to enhance reliability, protect workers, and lower the environmental footprint of industrial operations.
UniSieve
Seed Round in 2023
UniSieve develops and manufactures molecular sieving membranes for various applications. Its technology combines different molecular sieves with polymeric membranes to provide reliable separation solutions. UniSieve's products are used in chemical feedstock purification, biogas upgrading, sensing, space-related applications, gas separation, and liquid separation.
Founded in 2018, Nexoya is a Swiss-based company that develops an AI-driven platform for improving marketing performance. It aggregates key performance indicators (KPIs) from various tools and uses predictive analytics to optimize ad budget allocation across channels, enhancing return on ad spend by up to 30%.
Gerald Group
Debt Financing in 2023
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
tado°
Venture Round in 2023
tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.
Correntics
Pre Seed Round in 2023
Correntics is a company focused on enhancing the resilience of global supply chains through a climate risk assessment platform. By employing a data-driven approach, it provides clients with comprehensive insights into their supply chains, covering aspects from raw material availability to final delivery. The platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling businesses to identify and mitigate potential disruptions. Correntics aims to improve operational efficiency and financial stability for its clients while addressing the challenges posed by climate change and emerging risks, ultimately supporting the sustainability of their business activities.
Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.
Resistell
Series B in 2022
Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.
Insolight
Venture Round in 2022
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.
TerraRad Tech
Convertible Note in 2022
Specializes in drone-mounted sensors for measuring soil moisture and crop water content. Offers the turfRad line for golf courses, aiming to reduce irrigation water usage through actionable data.
Navignostics
Seed Round in 2022
Navignostics is a biotechnology company focused on improving cancer treatment through advanced diagnostic techniques. By employing spatial single-cell proteomics, Navignostics characterizes tumors to identify the most effective treatment strategies for individual cancer patients. The company aims to reduce patient suffering by personalizing cancer therapies and ensuring that the right drug is available for each unique case. In addition to enhancing patient outcomes, Navignostics accelerates cancer drug development by offering valuable insights into drug mechanisms and tumor characteristics, which are essential for the creation of companion diagnostics. Their robust technology and data analytics capabilities position the company as a key player in precision cancer diagnostics, providing support to both patients and pharmaceutical partners in the fight against cancer.
vestr
Venture Round in 2022
Vestr is a technology company that specializes in providing a comprehensive software-as-a-service platform designed for the management of actively managed investment products. The company focuses on digitizing the entire value chain of active management, offering tools that facilitate portfolio management, order execution, and performance reporting. By streamlining these processes, Vestr enables issuers and portfolio managers to concentrate on their core competencies while efficiently managing their portfolios. The platform addresses the complexities of active management, allowing clients to make informed investment decisions and mitigate risk without issuing its own structured products.
Avelo focuses on saving lives through swift and precise infectious disease diagnoses in primary care settings. It specializes in manufacturing breath aerosol diagnostic equipment designed to enhance tuberculosis diagnosis via a non-invasive, painless breath collection device. This enables faster, accurate diagnoses using existing PCR testing infrastructure, facilitating earlier appropriate treatment and rapid patient referral.
Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.
Piomic Medical
Series A in 2022
Piomic Medical is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly leg and foot ulcers. The company has created the COMS® One Therapy System, a portable, hand-held device that utilizes optical and magnetic stimulation technologies to promote wound healing. This device is designed to be user-friendly, featuring a single button operation, and can be utilized in both clinical settings and patients' homes. Clinical studies have demonstrated that the COMS® system is safe and effective, resulting in accelerated wound closure, reduced pain, and improved quality of life for patients. By providing a lightweight and efficient solution, Piomic Medical addresses the significant challenge posed by hard-to-heal wounds, which affect millions of individuals and impose a considerable burden on healthcare systems worldwide.
Pipra develops an AI-driven clinical decision support software that helps doctors identify high-risk patients prone to post-operative delirium prior to surgery. This tool integrates medical data analysis and predictive modeling, enabling healthcare providers to reduce complications and improve patient outcomes.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Founded in 2016, Smeetz is a Swiss-based company offering an AI-powered commerce intelligence platform tailored for the leisure and entertainment industry. Its comprehensive suite of solutions includes ticketing, POS, CRM, data analytics, and dynamic pricing, empowering venues to optimize efficiency, increase revenue, and enhance guest experiences.
Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.
Isochronic
Seed Round in 2022
Isochronic is a manufacturer of advanced industrial robotic products designed for pick-and-place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thus enhancing efficiency in high-volume production lines. By enabling industries to automate their operations, Isochronic significantly increases the number of products processed at any given time while optimizing the use of factory floor space. Its innovative approach aims to revolutionize the traditional pick-and-place methods, providing businesses with the tools necessary for streamlined operations and enhanced productivity.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.
Founded in 2018, 9T Labs specializes in manufacturing advanced 3D printers that produce carbon composites. Their proprietary technology combines software, additive manufacturing, and industry-standard materials to deliver digital composite production solutions. This enables manufacturers to create lighter structural parts with true 3D fiber orientation at a lower cost.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.
Drone Harmony
Seed Round in 2022
Founded in 2016, Drone Harmony specializes in developing software for cost-effective deployment of drone technology in industries where traditional methods fall short. Its flagship product is a 3D flight planning platform that transforms users into professional inspection operators by automating complex industrial tasks.
Nanoleq develops and manufactures electric cables using stretchable electronics, serving sectors such as healthcare, robotics, aerospace, and electronics. Its products include shields and conductors for various applications.
Hylomorph
Series B in 2021
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.
Seervision
Funding Round in 2021
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.
Founded in 2017, Scewo designs and manufactures innovative electric wheelchairs for individuals with mobility impairments. Its flagship product is a stair-climbing wheelchair that combines wheels and tracks with an active control system, enabling users to navigate various terrains and obstacles.
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.
RoomPriceGenie
Seed Round in 2021
RoomPriceGenie AG, founded in 2017 and based in Steinhausen, Switzerland, specializes in designing and developing revenue management software tailored for hotels, apartments, and vacation rentals. The company's platform offers sophisticated yielding, strategy foresight, and automated updates to optimize room pricing based on demand, occupancy, and availability. By leveraging advanced dynamic pricing algorithms and real-time analytics, RoomPriceGenie ensures optimal pricing strategies. It integrates seamlessly with various property management systems and channel managers, providing both automated pricing adjustments and manual control options. This makes it a versatile tool for small to medium-sized hotels aiming to boost their revenue efficiently. The platform is known for its user-friendly interface and excellent customer support.
Eldico Scientific
Seed Round in 2021
ELDICO Scientific AG is a Swiss company founded in 2019 and located at the Switzerland Innovation Park Innovaare, which is affiliated with the Paul Scherrer Institute. The company specializes in the development, manufacturing, and sale of electron diffractometers designed for the analysis of solid compounds, particularly targeting nano-crystalline systems in the sub-micrometer range. ELDICO's innovative instruments enable industrial and scientific researchers to characterize materials that were previously challenging to measure, thereby facilitating advancements in fields such as pharmaceuticals, agrochemicals, and advanced materials research. The company achieved proof of concept for its technology in 2018, with recognition from reputable scientific communities, including being named a Top 5 "Breakthrough of the Year" by a leading journal. This groundbreaking work positions ELDICO as a key player in enhancing the speed and cost-effectiveness of structural analysis, ultimately contributing to faster drug discovery and development processes.
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
Founded in 2018, Nexoya is a Swiss-based company that develops an AI-driven platform for improving marketing performance. It aggregates key performance indicators (KPIs) from various tools and uses predictive analytics to optimize ad budget allocation across channels, enhancing return on ad spend by up to 30%.
Futurae
Venture Round in 2021
Futurae, founded in 2016 as an ETH Zürich spin-off, provides an authentication platform that combines AI-based methods with regulatory-compliant features such as PSD2/SCA to reduce user friction, enhance the user experience, and lower support costs for clients. The platform also enables transaction confirmation and real-time fraud decisions, supporting banks, insurers, online shops, and wallets worldwide to deliver secure and seamless user journeys.
Apiax
Venture Round in 2021
Founded in 2017, Apiax specializes in digitalizing complex financial regulations. Its platform transforms regulatory requirements into manageable rules, enabling banks and FinTech companies to embed compliance directly into their workflows.
Microcaps
Seed Round in 2021
Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.
Synendos Therapeutics
Series A in 2020
Synendos Therapeutics AG is a biopharmaceutical company based in Allschwil, Switzerland, founded in 2019. It specializes in developing therapies for neuropsychiatric disorders, particularly focusing on anxiety, mood, and stress-related conditions. The company is pioneering a new class of small molecules that target the endocannabinoid system to restore natural brain function. By modulating cannabinoid activity and inhibiting endocannabinoid transport across cell membranes, Synendos aims to rebalance altered neurotransmission in various areas of the brain. This innovative approach addresses significant unmet medical needs, particularly for conditions such as post-traumatic stress disorder (PTSD), where there is a high demand for effective pharmacological treatments.
Voliro specializes in mobile robotics, focusing on innovative solutions for work at heights using advanced flying robots. Their proprietary tiltable rotor system enables precise interaction with the environment, allowing inspections even on curved surfaces. Voliro's drones are equipped with various Non-Destructive Testing (NDT) sensors and Lightning Protection System (LPS) sensors, enhancing safety and efficiency in asset inspection.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.
Insolight
Series A in 2020
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.
Vestr is a technology company that specializes in providing a comprehensive software-as-a-service platform designed for the management of actively managed investment products. The company focuses on digitizing the entire value chain of active management, offering tools that facilitate portfolio management, order execution, and performance reporting. By streamlining these processes, Vestr enables issuers and portfolio managers to concentrate on their core competencies while efficiently managing their portfolios. The platform addresses the complexities of active management, allowing clients to make informed investment decisions and mitigate risk without issuing its own structured products.
Artiria Medical
Series A in 2020
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.
Metaco is a Swiss company that specializes in providing digital asset management solutions for financial institutions. It offers a comprehensive orchestration platform that allows institutions to issue, secure, manage, and trade a diverse range of digital assets, including cryptocurrencies, tokens, and smart contracts. The company’s platform supports the entire lifecycle of asset tokens with a robust smart contract framework, facilitating the management of various asset classes such as equities, bonds, and derivatives. Metaco's technology ensures a secure and agile digital asset vault for self-custody, while also providing connectivity to over 50 exchanges, brokers, and market makers, thus enabling seamless trading and efficient risk management for its clients.
Positrigo
Series A in 2020
Positrigo develops and manufactures dedicated brain positron emission tomography (PET) scanners. Its mission is to make functional brain imaging accessible for early detection of neurodegenerative diseases like Alzheimer's, Lewy body dementia, vascular dementia, and frontotemporal dementia.
xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.
Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.
PXL Vision
Seed Round in 2020
PXL Vision is a Swiss identity verification software provider focused on automated, AI-based onboarding and fraud prevention. Its cross-platform Daego solution creates trusted digital identities for customer onboarding by verifying identity documents and performing liveness checks through computer vision and machine learning. Founded in 2017 and headquartered in Zurich, the company operates research and development centers in Novi Sad and Yerevan to advance high-performance ML-based verification. PXL Vision serves industries such as insurance, gambling, fintech, banking and healthcare with a modular, configurable system that supports fully automated identity verification, reduces dropout, improves onboarding conversion, and helps businesses comply with regulatory requirements while protecting customer data. The company emphasizes reliable verifications and safe digital interactions by leveraging proprietary machine learning to confirm document authenticity and user identity.
Livet designs and engineers medical devices. They include information on medical devices; a designed LED light source is built-in; and endoscopic examinations can be easily performed simply by connecting to a PC for monitoring.
Pregnolia
Series A in 2020
Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.
AVAtronics
Seed Round in 2020
Founded in 2016, AVAtronics specializes in developing noise-cancelling technology for electronic devices. Its Active Noise Cancellation (ANC) solution offers low power consumption and wide-band capabilities, selectively cancelling unwanted noises without compromising audio quality.
AnnAidA Technologies
Seed Round in 2020
Founded in 2019, AnnAidA Technologies specializes in developing innovative devices for biochemical research. Its flagship product, EmbryoSpin, enables chemical analysis at the scale of a single human embryo using microscopic Nuclear Magnetic Resonance technology.
Klepsydra Technologies
Grant in 2020
Klepsydra Technologies GmbH is a software development company based in Zurich, Switzerland, founded in 2017. It specializes in providing a lightweight, platform-agnostic software engineering toolset designed for embedded systems. The company’s software facilitates the development of high-performance applications across various sectors, including aerospace, robotics, autonomous unmanned aerial vehicles, smart mobility, and Internet of Things (IoT) solutions. By offering a cloud computing tool, Klepsydra enables clients to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks such as sensor fusion and image processing. This positions Klepsydra as a versatile enabler of innovation, helping clients achieve ambitious goals through enhanced efficiency and effectiveness in their engineering processes.
Archilyse
Series A in 2020
Archilyse AG is a Zurich-based software company founded in 2017 that specializes in numeric architectural analysis. The firm offers a Software-as-a-Service solution that enables real estate professionals, including portfolio managers and developers, to analyze and optimize various processes throughout the real estate lifecycle. Archilyse's software converts 2D floor plans into 3D models and utilizes a range of simulations—such as view, geometrical, connectivity, and physical analysis—to derive valuable insights about architectural quality. The application allows users to visualize data through heatmaps and export key performance metrics for further analysis. By addressing the information imbalance in the real estate sector, Archilyse enhances the decision-making capabilities of its clients, promoting a more data-driven approach to property evaluation and portfolio management.
Nagi Bioscience
Seed Round in 2019
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.
Resistell
Series A in 2019
Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
Founded in 2017, Apiax specializes in digitalizing complex financial regulations. Its platform transforms regulatory requirements into manageable rules, enabling banks and FinTech companies to embed compliance directly into their workflows.
Picstars
Venture Round in 2019
Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.